HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG) - ANVISA Registration 10287411331

Access comprehensive regulatory information for HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10287411331 and manufactured by ROCHE DIAGNOSTICS - GMBH. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until Apr 09, 2028.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ABBOTT IRELAND DIAGNOSTICS DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10287411331
2 Related Devices
Registration Details
ANVISA Registration Number: 10287411331
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

10287411331

25351418773201740

30280358000186

Company Information

Germany
PT: ALEMANHA

Dates and Status

Apr 09, 2018

09/04/2028

09/18/2025 19:00:01

Registration Details

10287411331

25351418773201740

30280358000186

Company Information

Dates and Status

Apr 09, 2018

09/04/2028

09/18/2025 19:00:01